All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Antineoplastic agents;monoclonal antibodies and antibody drug conjugates

Lunsumio

(mosunetuzumab)

Uses, side effects, dosage information & price range

Roche Registration GmbH

About this medicine

Lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior systemic therapies.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

OrblidComposition: bevacizumabLaboratoires Delbert
Price on RequestView Details →
DarzalexComposition: daratumumabJanssen-Cilag International N.V.
Price on RequestView Details →
PerjetaComposition: pertuzumabRoche Registration GmbH
Price on RequestView Details →

Key Information

Salt / Composition

mosunetuzumab

Category

Antineoplastic agents;monoclonal antibodies and antibody drug conjugates

Manufacturer

Roche Registration GmbH

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.